Most Recent
Jones Day adds White & Case lawyer for restructuring practice
Jones Day has recruited White & Case lawyer Kathryn Sutherland-Smith for the firm's business restructuring & reorganization practice in Sydney.
JWS lures partner from Jones Day for disputes and insolvency team
Johnson Winter Slattery has nabbed a Jones Day partner to work coast to coast at its Brisbane and Perth offices, bolstering the ranks of its disputes and insolvency team.
Sanofi defeats government’s $325M appeal over generic Plavix ban
Drug maker Sanofi-Aventis is not liable for the federal government’s losses for excess subsidies paid for the blood-thinner Plavix after an allegedly unjustified court injunction prevented the release of a generic version of the blockbuster drug, an appeals court has found.
In decades-long fight over coal seam gas fields, Tri-Star loses referee bid
Texas oil giant Tri-Star has lost its bid for a referral in a dispute with natural gas exporter Australia Pacific LNG over several coal seam gas fields in Queensland and $7.6 billion in share acquisitions.
Judge won’t stay reference in ‘monumental’ Santos, Fluor litigation
A judge won't stay a reference process which US company Fluor claims is infected with bias, in a "monumental" dispute with energy giant Santos that has already generated a $57.5 million legal bill for the engineering firm.
SMBC mulls new claims in $34M lawsuit over Forum Finance receivables
Japanese bank SMBC has foreshadowed an application to add claims against Humm Group after the fintech's subsidiary allegedly misled the bank about receivables under contracts forged by a Forum Group entity.
High Court to weigh in on penalties for foreign bribery violations
The High Court has agreed to hear prosecutors' appeal of a "manifestly inadequate" $1.35 million penalty against an engineering firm for bribing foreign officials in Vietnam to secure $10 million in infrastructure contracts.
Sanofi challenges Amgen’s patents for cholesterol-lowering antibodies
French drug giant Sanofi has appealed a decision giving American biopharmaceutical company Amgen the go-ahead for its patents for a cholesterol-lowering antibody that could be used to treat heart disease, diabetes, stroke and Alzheimer’s.
Jones Day snags intellectual property ace from Clayton Utz
US-based multinational firm Jones Day has lured a partner from Clayton Utz to join its intellectual property team in Melbourne.
Humm points finger at Forum Finance in SMBC’s $34M lawsuit
Fintech Humm has admitted to making “misrepresentations” to Japanese bank SMBC over allegedly worthless receivables linked to Forum Finance but has denied it was negligent, claiming a Forum Group unit should share the burden of paying any damages in the $33.6 million lawsuit.